^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PLX038

    i
    Other names: PLX038, long-acting PEGylated SN-38, PEG-SN-38, DFP-13318, PLX-0264, Polyethylene-glycol-SN 38-conjugates, polyethyleneglycol-7-ethyl-10-hydroxycamptothecin, ultra-long acting PEG-SN38, PLX-038
    Company:
    ProLynx
    Drug class:
    Topoisomerase I inhibitor, DDR enhancer
    Related drugs:
    Apply
    PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications (NCT06161519)
    Phase 1/2
    National Cancer Institute (NCI)
    Recruiting
    Last update posted :
    06/05/2024
    Initiation :
    01/31/2024
    Primary completion :
    11/14/2028
    Completion :
    11/14/2033
    MYCN
    |
    MYCN amplification
    |
    PLX038